000			01245 a2200229 4500
005			20250517123426.0
264		0	_c20180301
008			201803s 0 0 eng d
022			_a1873-2496
024	7		_a10.1016/j.urolonc.2016.02.004 _2doi
040			_aNLM _beng _cNLM
100	1		_aLin, Daniel
245	0	0	_aCommentary on "The evolutionary history of lethal metastatic prostate cancer." Gundem G, Van Loo P, Kremeyer B, Alexandrov LB, Tubio JM, Papaemmanuil E, Brewer DS, Kallio HM, Högnäs G, Annala M, Kivinummi K, Goody V, Latimer C, O'Meara S, Dawson KJ, Isaacs W, Emmert-Buck MR, Nykter M, Foster C, Kote-Jarai Z, Easton D, Whitaker HC, ICGC Prostate UK Group, Neal DE, Cooper CS, Eeles RA, Visakorpi T, Campbell PJ, McDermott U, Wedge DC, Bova GS, University of Washington-Urology, Seattle, WA. Nature 2015; 520(7547):353-7. _h[electronic resource]
260			_bUrologic oncology _c11 2016
300			_a520-521 p. _bdigital
500			_aPublication Type: Journal Article; Comment
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aProstatic Neoplasms
773	0		_tUrologic oncology _gvol. 34 _gno. 11 _gp. 520-521
856	4	0	_uhttps://doi.org/10.1016/j.urolonc.2016.02.004 _zAvailable from publisher's website
999			_c26578361 _d26578361